289 related articles for article (PubMed ID: 15728547)
1. Thrombospondin plays a vital role in the immune privilege of the eye.
Zamiri P; Masli S; Kitaichi N; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):908-19. PubMed ID: 15728547
[TBL] [Abstract][Full Text] [Related]
2. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
[TBL] [Abstract][Full Text] [Related]
3. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants.
Grisanti S; Ishioka M; Kosiewicz M; Jiang LQ
Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1619-26. PubMed ID: 9224290
[TBL] [Abstract][Full Text] [Related]
4. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells.
Yoshida M; Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3862-70. PubMed ID: 11053287
[TBL] [Abstract][Full Text] [Related]
5. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
Yoshida M; Takeuchi M; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
[TBL] [Abstract][Full Text] [Related]
6. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M
Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837
[TBL] [Abstract][Full Text] [Related]
7. Evidence that retinal pigment epithelium functions as an immune-privileged tissue.
Wenkel H; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3467-73. PubMed ID: 11006240
[TBL] [Abstract][Full Text] [Related]
8. Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells.
Miyajima-Uchida H; Hayashi H; Beppu R; Kuroki M; Fukami M; Arakawa F; Tomita Y; Kuroki M; Oshima K
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):561-7. PubMed ID: 10670489
[TBL] [Abstract][Full Text] [Related]
9. Activation of TGF-beta1 through up-regulation of TSP-1 by retinoic acid in retinal pigment epithelial cells.
Uchida H; Kuroki M; Shitama T; Hayashi H; Kuroki M
Curr Eye Res; 2008 Feb; 33(2):199-203. PubMed ID: 18293192
[TBL] [Abstract][Full Text] [Related]
10. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro.
Flügel-Koch C; Ohlmann A; Fuchshofer R; Welge-Lüssen U; Tamm ER
Exp Eye Res; 2004 Nov; 79(5):649-63. PubMed ID: 15500824
[TBL] [Abstract][Full Text] [Related]
12. The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro.
Kaestel CG; Lovato P; Ødum N; Nissen MH; Röpke C
Curr Eye Res; 2005 May; 30(5):375-83. PubMed ID: 16020268
[TBL] [Abstract][Full Text] [Related]
13. Antigen-presenting cells are targets of regulatory T cells similar to those that mediate anterior chamber-associated immune deviation.
Yokoi H; Streilein JW
Ocul Immunol Inflamm; 2004 Jun; 12(2):101-14. PubMed ID: 15512980
[TBL] [Abstract][Full Text] [Related]
14. Analysis of immune deviation elicited by antigens injected into the subretinal space.
Wenkel H; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.
Grainger DJ; Frow EK
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):291-8. PubMed ID: 10926856
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of B7H1 on retinal pigment epithelial cells.
Usui Y; Okunuki Y; Hattori T; Kezuka T; Keino H; Ebihara N; Sugita S; Usui M; Goto H; Takeuchi M
Exp Eye Res; 2008 Jan; 86(1):52-9. PubMed ID: 17981268
[TBL] [Abstract][Full Text] [Related]
18. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.
Ohta K; Yamagami S; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2591-9. PubMed ID: 10937571
[TBL] [Abstract][Full Text] [Related]
19. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
[TBL] [Abstract][Full Text] [Related]
20. Ovalbumin serves as a neo-transplantation antigen in retinal pigment epithelial cells.
Wajchman JR; Zimring JC; Lake JP; Wen J; Kapp JA
Mol Vis; 2007 Oct; 13():1902-11. PubMed ID: 17960129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
